Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Pulmonary Hypertension

Free Subscription 08.04.2024 1 Acta Pharm Sin B 1 Am J Cardiol 1 Am J Respir Crit Care Med 1 Arch Bronconeumol 1 Arterioscler Thromb Vasc Biol 1 Circulation 1 Clin Kidney J 1 Clin Res Cardiol 1 Cureus 1 Curr Hypertens Rep 1 Curr Pharm Biotechnol 1 Eur J Cardiothorac Surg 1 Eur J Med Res 2 Eur J Pharmacol 1 Eur Radiol Exp 1 Eur Respir J 1 Int Heart J 1 Int Immunopharmacol 1 J Am Coll Cardiol 1 J Pediatr 1 Lancet Respir Med 1 PLoS One 1 Pulm Circ 1 Respir Med Case Rep 1 Respir Res 2 Rheumatology (Oxford) 2 Sarcoidosis Vasc Diffuse Lung Dis 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Pharm Sin B

1. XING Y, Hou Y, Fan T, Gao R, et al
   Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension.
   Acta Pharm Sin B. 2024;14:1726-1741.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. CELESKI M, Segreti A, Polito D, Valente D, et al
   Traditional and Advanced Echocardiographic Evaluation in Chronic Obstructive Pulmonary Disease: The Forgotten Relation.
   Am J Cardiol. 2024;217:102-118.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

3. BJORKMAN KR, Miles KG, Bellew LE, Schneider KA, et al
   Patent Ductus Arteriosus and Lung MRI Phenotype in Moderate and Severe Bronchopulmonary Dysplasia-Pulmonary Hypertension.
   Am J Respir Crit Care Med. 2024 Apr 3. doi: 10.1164/rccm.202310-1733.
   PubMed         Abstract available
   
   

   
   Arch Bronconeumol

4. MARTINEZ-MENACA A, Mora-Cuesta VM, Iturbe-Fernandez D, Sainz-Ezquerra Belmonte B, et al
   Quality of Life and the Cardiopulmonary Exercise Test in Pulmonary Arterial Hypertension Patients.
   Arch Bronconeumol. 2024;60:253-255.
   PubMed        
   
   

   
   Arterioscler Thromb Vasc Biol

5. KONG D, Liu J, Lu J, Zeng C, et al
   HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension.
   Arterioscler Thromb Vasc Biol. 2024 Apr 4. doi: 10.1161/ATVBAHA.123.319916.
   PubMed         Abstract available
   
   

   
   Circulation

6. SHEN H, Gao Y, Ge D, Tan M, et al
   BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension.
   Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.123.066430.
   PubMed         Abstract available
   
   

   
   Clin Kidney J

7. NASSAR GM, Jameson R, Sathiyaraj S, Bidikian N, et al
   Recovery from kidney failure associated with chronic thromboembolic pulmonary hypertension following pulmonary thomboendarterectomy.
   Clin Kidney J. 2024;17:sfae047.
   PubMed         Abstract available
   
   

   
   Clin Res Cardiol

8. JAEGER P, Toskas I, Henes JK, Shcherbyna S, et al
   Impact of pulmonary hypertension on outcomes after TEER in patients suffering from mitral regurgitation.
   Clin Res Cardiol. 2024 Apr 2. doi: 10.1007/s00392-024-02442.
   PubMed         Abstract available
   
   

   
   Cureus

9. KHEMCHANDANI M, Nasir K, Qureshi R, Dhrolia M, et al
   Frequency of Pulmonary Hypertension and Its Associated Risk Factors in End-Stage Renal Disease (ESRD) Patients on Maintenance Hemodialysis.
   Cureus. 2024;16:e55206.
   PubMed         Abstract available
   
   

   
   Curr Hypertens Rep

10. KOZAILY E, Akdogan ER, Dorsey NS, Tedford RJ, et al
    Management of Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction.
    Curr Hypertens Rep. 2024 Apr 1. doi: 10.1007/s11906-024-01296.
    PubMed         Abstract available
    
    

    
    Curr Pharm Biotechnol

11. HU X, Lv X, Zhang L, Li SS, et al
    Noncoding RNA Lipotherapeutics: A Promising Breakthrough in Pulmonary Hypertension Treatment.
    Curr Pharm Biotechnol. 2024 Mar 29. doi: 10.2174/0113892010302590240321073509.
    PubMed         Abstract available
    
    

    
    Eur J Cardiothorac Surg

12. DATE N, Nakajima D, Ikeda M, Nishikawa S, et al
    Effect of epoprostenol-induced thrombocytopaenia on lung transplantation for pulmonary arterial hypertension.
    Eur J Cardiothorac Surg. 2024 Mar 27:ezae108. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Eur J Med Res

13. TANG M, Luo J, Liu Q, Song J, et al
    Coexistence of pulmonary arterial hypertension and straight back syndrome in a patient with a novel BMPR2 variant affecting cytoplasmic tail domain.
    Eur J Med Res. 2024;29:209.
    PubMed         Abstract available
    
    

    
    Eur J Pharmacol

14. WANG J, Liu C, Huang SS, Wang HF, et al
    Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension.
    Eur J Pharmacol. 2024;970:176492.
    PubMed         Abstract available
    
    
15. CHEN Y, Liu J, Zhang Q, Chai L, et al
    Activation of CaMKII/HDAC4 by SDF1 contributes to pulmonary arterial hypertension via stabilization Runx2.
    Eur J Pharmacol. 2024;970:176483.
    PubMed         Abstract available
    
    

    
    Eur Radiol Exp

16. OKI T, Nagatani Y, Ishida S, Hashimoto M, et al
    Right main pulmonary artery distensibility on dynamic ventilation CT and its association with respiratory function.
    Eur Radiol Exp. 2024;8:50.
    PubMed         Abstract available
    
    

    
    Eur Respir J

17. AGARWAL S, Fineman J, Cornfield DN, Alvira CM, et al
    VIEWING PULMONARY HYPERTENSION THROUGH A PEDIATRIC LENS.
    Eur Respir J. 2024 Apr 4:2301518. doi: 10.1183/13993003.01518-2023.
    PubMed        
    
    

    
    Int Heart J

18. WANG S, Li H, Liu Q, Ma H, et al
    Hydroxycitric Acid Tripotassium Hydrate Attenuates Monocrotaline and Hypoxia-Induced Pulmonary Hypertension in Rats.
    Int Heart J. 2024;65:318-328.
    PubMed         Abstract available
    
    

    
    Int Immunopharmacol

19. LI X, Song L, Lu Z, Tong S, et al
    Integrative analyses of whole-transcriptome sequencing reveals CeRNA regulatory network in pulmonary hypertension treated with FGF21.
    Int Immunopharmacol. 2024;132:111925.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

20. BEKHUIS Y, Verwerft J, Claessen G
    Exercise Echocardiography for mPAP/CO Slope Estimation: A New Standard for Routine Clinical Care?
    J Am Coll Cardiol. 2024;83:e141-e142.
    PubMed        
    
    

    
    J Pediatr

21. CRITSER PJ, Buchmiller TL, Gauvreau K, Zalieckas JM, et al
    Exercise-induced Pulmonary Hypertension in Long-term Survivors of Congenital Diaphragmatic Hernia.
    J Pediatr. 2024 Mar 27:114034. doi: 10.1016/j.jpeds.2024.114034.
    PubMed         Abstract available
    
    

    
    Lancet Respir Med

22. THE EDITORS OF THE LANCET RESP
    Retraction and republication-Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
    Lancet Respir Med. 2024;12:262-263.
    PubMed        
    
    

    
    PLoS One

23. MATSUNAGA T, Kono A, Nishio M, Yoshii T, et al
    Development and web deployment of prediction model for pulmonary arterial pressure in chronic thromboembolic pulmonary hypertension using machine learning.
    PLoS One. 2024;19:e0300716.
    PubMed         Abstract available
    
    

    
    Pulm Circ

24. ZHANG P, Da Silva Goncalves Bos D, Vang A, Feord J, et al
    Reduced exercise capacity occurs before intrinsic skeletal muscle dysfunction in experimental rat models of pulmonary hypertension.
    Pulm Circ. 2024;14:e12358.
    PubMed         Abstract available
    
    

    
    Respir Med Case Rep

25. VAN KALSBEEK D, Anani AR, El-Kersh K
    Pulmonary artery vasodilators for treatment of pulmonary hypertension complicating fibrosing mediastinitis.
    Respir Med Case Rep. 2024;49:102006.
    PubMed         Abstract available
    
    

    
    Respir Res

26. ZUO Y, Li B, Gao M, Xiong R, et al
    Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension.
    Respir Res. 2024;25:147.
    PubMed         Abstract available
    
    

    
    Rheumatology (Oxford)

27. TODOROKI Y, Satoh M, Kubo S, Kosaka S, et al
    Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in mixed connective tissue disease.
    Rheumatology (Oxford). 2024;63:1068-1075.
    PubMed         Abstract available
    
    
28. DISTLER O, Ofner C, Huscher D, Jordan S, et al
    Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.
    Rheumatology (Oxford). 2024;63:1139-1146.
    PubMed         Abstract available
    
    

    
    Sarcoidosis Vasc Diffuse Lung Dis

29. PRICE LC, Kouranos V, Baughman R, Bloom C, et al
    Use of pulmonary arterial hypertension therapies in patient swith sarcoidosis-associated pulmonary hypertension.
    Sarcoidosis Vasc Diffuse Lung Dis. 2024;41:e2024024.
    PubMed        
    
    
30. GEGENAVA M, Gegenava T
    Association of pulmonary hypertension with outcomes in patients with Systemic sclerosis and other connective tissue disorders: review and meta-analysis.
    Sarcoidosis Vasc Diffuse Lung Dis. 2024;41:e2024023.
    PubMed         Abstract available
    
    

    
    Transplant Proc

31. STACEL T, Kegler K, Medrala A, Sybila P, et al
    Lung Transplantation in Patients With Pulmonary Hypertension With Extracorporeal Membrane Oxygenation (ECMO) Support: 5-Year Experience.
    Transplant Proc. 2024 Apr 4:S0041-1345(24)00170.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.